Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,212 | 172,012 | 175,530 | 119,806 | 133,958 |
| Marketable Securities | 267,491 | 197,895 | 71,000 | 69,000 | 69,000 |
| TOTAL | $357,889 | $374,521 | $250,942 | $191,466 | $204,414 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 10,100 | 4,286 | 3,724 | 2,395 | 2,639 |
| TOTAL | $10,100 | $4,286 | $3,724 | $2,395 | $2,639 |
| Total Assets | $367,989 | $378,807 | $254,666 | $193,861 | $207,053 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,341 | 862 | 1,513 | 1,138 | 829 |
| Accrued Expenses | 12,782 | 10,042 | 9,708 | 7,756 | 5,179 |
| TOTAL | $16,368 | $11,072 | $11,550 | $9,382 | $6,598 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 99,868 | 95,324 | 95,324 | 95,324 | 95,377 |
| TOTAL | $99,868 | $95,324 | $95,324 | $95,324 | $95,377 |
| Total Liabilities | $116,236 | $106,396 | $106,874 | $104,706 | $101,975 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,425 | 54,913 | 54,903 | 36,296 | 28,041 |
| Common Shares | 55 | 55 | 41 | 28 | 28 |
| Retained earnings | -624,634 | -600,462 | -580,534 | -549,124 | -531,397 |
| Other shareholders' equity | -45 | -14 | 0 | 0 | 0 |
| TOTAL | $251,753 | $272,411 | $147,792 | $89,155 | $105,078 |
| Total Liabilities And Equity | $367,989 | $378,807 | $254,666 | $193,861 | $207,053 |